Pubblicazioni scientifiche
-
Berardi A.; Rossi C.; Fiorini V.; Rivi C.; Vagnarelli F.; Guaraldi N.; Pietrosemoli P.; Lazzarotto T.; Ferrari F., Severe acquired cytomegalovirus infection in a full-term, formula-fed infant: case report., «BMC PEDIATRICS», 2011, 11, pp. 52 - 55 [Articolo in rivista]
-
Ruggeri F.M.; Delogu R.; Petouchoff T.; Tcheremenskia O.; De Pretis S.; Fiore L.; Lazzarotto T.; RotaNet-Italy Study group., Molecular characterization of rotavirus strains from children with diarrehea in Italy, 2007-2009., «JOURNAL OF MEDICAL VIROLOGY», 2011, 83, pp. 1657 - 1668 [Articolo in rivista]
-
Lanari M.; Capretti M.G.; Lazzarotto T., Neuroimaging examinations of newborns in vertically acquired infections., «THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE», 2011, 24, pp. 117 - 119 [Articolo in rivista]
-
Lazzarotto T.; Lanari M., Why is cytomegalovirus the most frequent cause of congenital infection?, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2011, 9, pp. 841 - 843 [Recensione in rivista]
-
C. Gualandi; M.L. Focarete; M. Govoni; E. Giordano; L. Foroni; S. Valente; G. Pasquinelli, Effect of ethanol treatment on Poly(L)lactic acid electrospun fibre morphology, in: Atti del Congresso Nazionale SIB 2010, S.N., s.n, 2011, pp. 86 - 86 (atti di: Congresso Nazionale SIB 2010, Camogli (Italy), 24-26 Maggio 2010) [Riassunto (Abstract)]
-
M.L. Focarete; C. Gualandi; M Soccio; N. Lotti; M. Govoni; E. Giordano; L. Foroni; S. Valente; G. Pasquinelli, New biodegradable polyesters for soft tissue engineering, in: Atti del Congresso Nazionale SIB 2010, S.N., s.n, 2011, pp. 82 - 82 (atti di: Congresso Nazionale SIB 2010, Camogli (Italy), 24-26 Maggio 2010) [Riassunto (Abstract)]
-
Dall’Olio F.; Malagolini N.; Chiricolo M., Glycosylation in cancer, in: Carbohydrate Chemistry. Chemical and Biological Approaches, CAMBRIDGE, RSC Publishing, 2011, pp. 21 - 56 [Capitolo/Saggio in libro]
-
Nicolini F.E.; Basak G.W.; Soverini S.; Martinelli G.; Mauro M.J.; Müller M.C.; Hochhaus A.; Chuah C.; Dufva I.H.; Rege-Cambrin G.; Saglio G.; Michallet M.; Labussière H.; Morisset S.; Hayette S.; Etienne G.; Olavarria E.; Zhou W.; Peter S.; Apperley J.F.; Cortes J., Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias., «BLOOD», 2011, 118(20), pp. 5697 - 5700 [Articolo in rivista]
-
Soverini S.; Hochhaus A.; Nicolini F.E.; Gruber F.; Lange T.; Saglio G.; Pane F.; Müller M.C.; Ernst T.; Rosti G.; Porkka K.; Baccarani M.; Cross N.C.; Martinelli G., Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet., «BLOOD», 2011, 118(5), pp. 1208 - 1215 [Articolo in rivista]
-
Giacomucci E; Bellavia E; Sandri F; Farina A; Scagliarini G., Term delivery rate after hysteroscopic metroplasty in patients with recurrent spontaneous abortion and T-shaped, arcuate and septate uterus., «GYNECOLOGIC AND OBSTETRIC INVESTIGATION», 2011, 71, pp. 183 - 188 [Articolo in rivista]
-
Kang JH; Song H; Yoon JA; Park DY; Kim SH; Lee KJ; Farina A; Cho YK; Kim YN; Park SW; Kim GJ; Shim SH; Cha DH., Preeclampsia leads to dysregulation of various signaling pathways in placenta., «JOURNAL OF HYPERTENSION», 2011, 29, pp. 928 - 936 [Articolo in rivista]
-
Casadio P; Youssef AM; Spagnolo E; Rizzo MA; Talamo MR; De Angelis D; Marra E; Ghi T; Savelli L; Farina A; Pelusi G; Mazzon I, Should the myometrial free margin still be considered a limiting factor for hysteroscopic resection of submucous fibroids? A possible answer to an old question, «FERTILITY AND STERILITY», 2011, 95, pp. 1764 - 1768 [Articolo in rivista]
-
Farina A, Nonabortal pregnancy complications of chorionic villous sampling., «CURRENT OPINION IN OBSTETRICS & GYNECOLOGY», 2011, 23, pp. 129 - 134 [Articolo in rivista]
-
Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M., Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2011, 11(6), pp. 462 - 466 [Articolo in rivista]
-
Curti A.; Ruggeri L.; D'Addio A.; Bontadini A.; Dan E.; Motta M.R.; Trabanelli S.; Giudice V.; Urbani E.; Martinelli G.; Paolini S.; Fruet F.; Isidori A.; Parisi S.; Bandini G.; Baccarani M.; Velardi A.; Lemoli R.M., Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients., «BLOOD», 2011, 118, pp. 3273 - 3279 [Articolo in rivista]
-
Zinzani P.L.; Pellegrini C.; Broccoli A.; Stefoni V.; Gandolfi L.; Quirini F.; Argnani L.; Berti E.; Derenzini E.; Pileri S.; Baccarani M., Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified., «LEUKEMIA & LYMPHOMA», 2011, 52, pp. 1585 - 1588 [Articolo in rivista]
-
Roncolato F.; Gazzola A.; Zinzani P.L.; Pileri S.A.; Piccaluga P.P., Targeted molecular therapy in peripheral T-cell lymphomas, «EXPERT REVIEW OF HEMATOLOGY», 2011, 4, pp. 551 - 562 [Articolo in rivista]
-
Zinzani P.L.; Piccaluga P.P., Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies., «CURRENT ONCOLOGY REPORTS», 2011, 13, pp. 407 - 415 [Articolo in rivista]
-
Weisenburger D.D.; Savage K.J.; Harris N.L.; Gascoyne R.D.; Jaffe E.S.; MacLennan K.A.; Rüdiger T.; Pileri S.; Nakamura S.; Nathwani B.; Campo E.; Berger F.; Coiffier B.; Kim W.S.; Holte H.; Federico M.; Au W.Y.; Tobinai K.; Armitage J.O.; Vose J.M.; Zinzani P.L., Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project., «BLOOD», 2011, 117, pp. 3402 - 3408 [Articolo in rivista]
-
Morabito F.; Gentile M.; Mazzone C.; Rossi D.; Di Raimondo F.; Bringhen S.; Ria R.; Offidani M.; Patriarca F.; Nozzoli C.; Petrucci M.T.; Benevolo G.; Vincelli I.; Guglielmelli T.; Grasso M.; Marasca R.; Baldini L.; Montefusco V.; Musto P.; Cascavilla N.; Majolino I.; Musolino C.; Cavo M.; Boccadoro M.; Palumbo A., Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment., «BLOOD», 2011, 118, pp. 5759 - 5766 [Articolo in rivista]